Skip to main content
Home
866.776.5907
Glassdoor link
Linkedin link
Twitter link
Youtube link
  • Diagnostic Services
  • Pharma Services
  • Data Services
  • Test Menu
  • Client Services
  • Billing
  • Company
  • NEOLINK ® LOG IN
866.776.5907
Search Form Mobile Toggle
Mobile Menu Toggle

Tests in the Spotlight at NeoGenomics

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Start with NeoGenomics

Sidebar Sitemap Menu

  • New Tests
  • Test Methodologies
    • Cytogenetics
    • FISH
    • Flow Cytometry
    • IHC & ISH
    • Molecular
  • Specialty Testing
    • Hematopathology
      • Overview
      • COMPASS®
    • Solid Tumors
      • Overview
      • CancerTYPE ID®
    • NeoTYPE® Cancer Profiles
      • Overview
      • NeoTYPE® Cancer-Specific Profiles
      • NeoTYPE® Broad Reach Tumor Profiles
    • Liquid Biopsy Testing
    • NeoLAB® Liquid Biopsy
      • NeoLAB® Solid Tumor
      • NeoLAB® Heme
    • NCI-MATCH
    • Pediatric Oncology
    • Hereditary Cancer
  • Test Spotlight
  • Tech-Only Program
    • Overview
    • Virtual HemeFISH®
  • Laboratory Collaboration
  • Sponsored Testing Program
  • Get Started with NeoGenomics

Learn More About Our Most Popular and Innovative Tests

Test Spotlights are articles with expanded details about selected tests and services at NeoGenomics. Many articles are supplemented with references, images, downloadable brochures, frequently asked questions, sample reports, and more.

Please explore the following topics.

  • PIK3CA Mutation CDx – Tissue and Plasma
  • CancerTYPE ID® with reflex to NeoTYPE® Cancer Profile
  • COMPASS®
  • HER2 Breast Resources for 2018 CAP/ASCO Guideline Update
  • Breast Cancer Featured Tests
  • Hereditary Cancer & Genetic Counseling
  • Comprehensive Sarcoma Dx Services
  • NeoLAB® Liquid Biopsy for Hematologic Diseases
  • BTK Inhibitor Resistance and Susceptibility
  • Calreticulin (CALR) Mutation Analysis
  • NeoARRAY® SNP/Cytogenetic Profile
  • NeoSITE® Melanoma
Image
NeoGenomics White Logo

12701 Commonwealth Dr., Suite 9
Fort Myers, FL 33913
T: 239.768.0600
F: 239.690.4237

Glassdoor link
Linkedin link
Twitter link
Youtube link
Image
CAP logo
Image
CLIA logo

Resources

  • Contact Us
  • Careers
  • Corporate Stewardship
  • Licensing
  • Terms
  • Privacy
  • Do Not Sell My Personal Information

More From Neo

  • Blog: Powering Precision
  • KRAS G12C
  • Sponsored Testing Program
  • PIK3CA Mutation CDx
  • NTRK Gene Fusion Testing
  • Thyroid Cancer Testing Program
  • InVisionFirst®-Lung

Sign Up

Receive weekly updates on NeoGenomics tests, research, events, and publications.

© 2020 NeoGenomics Laboratories, Inc.

Close Menu

Sitemap Menu

  • Diagnostic Services
    • New Tests
    • Test Methodologies
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • IHC & ISH
      • Molecular
    • Specialty Testing
      • Hematopathology
        • Overview
        • COMPASS®
      • Solid Tumors
        • Overview
        • CancerTYPE ID®
      • NeoTYPE® Cancer Profiles
        • Overview
        • NeoTYPE® Cancer-Specific Profiles
        • NeoTYPE® Broad Reach Tumor Profiles
      • Liquid Biopsy Testing
      • NeoLAB® Liquid Biopsy
        • NeoLAB® Solid Tumor
        • NeoLAB® Heme
      • NCI-MATCH
      • Pediatric Oncology
      • Hereditary Cancer
    • Test Spotlight
    • Tech-Only Program
      • Overview
      • Virtual HemeFISH®
    • Laboratory Collaboration
    • Sponsored Testing Program
    • Get Started with NeoGenomics
  • Pharma Services
    • Pharma Services Portal
    • Pharma Services
      • Overview
      • Ordering Logistics
      • Quality and Compliance
    • Why Choose NeoGenomics
      • Overview
      • Global Capabilties
      • Expertise
    • Lab Services
      • Overview
      • Anatomic Pathology
      • Multiplexing IF
        • Overview
        • MultiOmyx™
          • Technologies
            • Hyperplexed Immunofluorescence Assay
            • IF + RNAScope Assay
            • IF Assay + NGS from ROI
            • IF Assay + DNA FISH
          • Applications
            • Immune Cells
            • Tumor Infiltrating Lymphocyte Panel
            • Expression of PD-L1
            • HBV Infection
        • Vectra Polaris™
        • Data Image Analysis
        • FAQs
      • Flow Cytometry
      • FISH
      • Cytogenetics
      • Immunoassays
      • Vaccines
      • Molecular
        • Overview
        • Regulated Sequencing
        • Sanger Sequencing
        • Viral Genotyping
        • Bioinformatics Services
        • Microbial Identification
        • NanoString Services
          • Overview
          • nCounter PanCancer Immune Profiling Panel
        • Next-Generation Sequencing Services
          • Overview
          • Whole Exome Sequencing
          • DNA Hybridization Capture Target Enrichment
          • PCR-based Target Enrichment
          • RNA Sequencing (RNA-Seq)
        • qPCR Services
    • CDx Services
      • Overview
      • CDx Development
      • Our Team
      • Assay Development and Validation
      • Technology Platforms and Partners
      • Regulatory and Useful Links
      • Commercialization
    • IVD Services
    • Transfer and Validate Biomarker Assays
    • Request More Information
  • Data Services
    • Overview
    • Data Solutions
    • Clinical Trial Solutions
  • Test Menu
  • Client Services
    • Test Ordering & Pickup
      • Overview
      • Forms and Kits
      • Specimen Pick-Up
      • Online Ordering
    • Education
      • Blog: Powering Precision
      • NeoUniversity™
      • Publications, Abstracts, and Posters
      • Webinars
        • Upcoming Webinars
        • On-Demand Webinars
      • Molecular Tumor Board
  • Billing
  • Company
    • Overview
    • Leadership
      • Leadership Team
      • Board of Directors
      • Medical and Scientific Team
      • Scientific Advisory Board
    • Careers
      • Overview
      • Benefits
    • Events
    • Investors
    • Newsletter
    • Press Releases
    • Regulatory
    • Corporate Stewardship
    • Contact Us
  • NEOLINK ® LOG IN
sfy39587stp16